ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Flagship Pioneering, Inc.
FL106 Inc. is seeking a Research Associate to generate high-quality data on the biodistribution, target engagement, and biological response of molecules in animal models. This role involves conducting in vivo studies, performing histology and imaging analysis, and executing molecular biology techniques to support the development of novel drug delivery modalities. The position requires a collaborative and independent professional to contribute to an early-stage biotechnology company's growth.
Headquarters
Cambridge, Massachusetts, United States
Company Size
201-500 employees
Founded
2000
Flagship Pioneering is a venture creation and investment firm that invents, builds, and funds early-stage companies in biotechnology, life sciences, and sustainability. Using an integrated model of in-house science, lab infrastructure, capital, and operational support, it spins out and scales breakthrough ventures — it has helped found more than 100 companies, including high-profile names such as Moderna. Flagship focuses on deep‑science innovation and long‑term partnerships to translate novel discoveries into transformative products for human health and the planet.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Flagship Pioneering, Inc..
37% above the average for this role
individual investors who own 52% along with institutions invested in Seres Therapeutics, Inc. (NASDAQ:MCRB) saw increase in their holdings value last week
Jul 20, 2025
UNIV - Staff Scientist - Department of Regenerative Medicine
Medical University of South Carolina (MUSC)
Researcher 3-Neurology
The Ohio State University
Biologist - Psychiatry, Pain and Neuronal Health Discovery
Eli Lilly and Company
Research Specialist II – Dr. Sungjin Ko’s Laboratory
Medical University of South Carolina (MUSC)
Senior Scientist - Cell-Based Assays
St. Jude Children's Research Hospital
Postdoctoral Scholar - Orthopedics
pennstate.edu
